Enveric Biosciences Expands Protection For EB-002 Drug Candidate With New U.S. Patent; Includes Broad Claims For Treating Brain Neurological Disorders
Enveric Biosciences Expands Protection For EB-002 Drug Candidate With New U.S. Patent; Includes Broad Claims For Treating Brain Neurological Disorders
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.